← All organizations
Highest phase reached
Phase 3
First clinical trial
May 24, 2016First marketed drug
Dec 19, 2024First NDA
Dec 19, 2024Last known activity
Dec 19, 2024
Timeline
2000s
- Jan 1, 2004
Humacyte, Inc.— Founded
2020s
- Dec 19, 2024
acellular tissue engineered vessel— NDA Organization
Drugs by trial phase (1 distinct, 7 trials)
Phase 3 (1 own, 0 via acquisition)
Marketed drugs (1)
Recent trials (11)
- NCT03631056Lead sponsorN/A—
- NCT07141641Lead sponsorN/A—
- NCT05908084Lead sponsorPhase 3Sep 7, 2023
- NCT03005418OfficialPhase 2/Phase 3Sep 1, 2018
- NCT03005418Lead sponsorPhase 2/Phase 3Sep 1, 2018
- NCT03183245Lead sponsorPhase 3Sep 29, 2017
- NCT03183245OfficialPhase 3Sep 29, 2017
- NCT02887859OfficialPhase 2Dec 20, 2016
- NCT02887859Lead sponsorPhase 2Dec 20, 2016
- NCT02644941Lead sponsorPhase 3May 24, 2016
- NCT02644941OfficialPhase 3May 24, 2016
Details
- Founded
- Durham, NC, US Jan 1, 2004
- First NDA
- Dec 19, 2024
- Last known activity
- Dec 19, 2024